Genprex, Inc. (GNPX) Financial Statements (2026 and earlier)

Company Profile

Business Address 1601 TRINITY STREET, BLDG. B
AUSTIN, TX 78712
State of Incorp. TX
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7,830,8551,601,6606,737,62920,954,06938,628,87627,319,685
Cash and cash equivalent7,830,8551,601,6606,737,62920,954,06938,628,87627,319,685
Receivables    34,852 127
Other undisclosed current assets525,928475,807794,138484,224511,3483,395,595
Total current assets:8,356,7832,077,4677,531,76721,473,14539,140,22430,715,407
Noncurrent Assets
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization   7,85923,03248,60839,441
Other noncurrent assets1,802,2282,046,8583,130,9663,588,8503,673,454612,366
Total noncurrent assets:1,802,2282,046,8583,138,8253,611,8823,722,062651,807
TOTAL ASSETS:10,159,0114,124,32510,670,59225,085,02742,862,28631,367,214
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:743,0701,074,2951,397,610442,925973,195192,968
Other undisclosed accounts payable and accrued liabilities743,0701,074,2951,397,610442,925973,195192,968
Other liabilities1,431,5651,429,8751,856,5982,367,362612,100257,756
Total current liabilities:2,174,6352,504,1703,254,2082,810,2871,585,295450,724
Noncurrent Liabilities
Other undisclosed noncurrent liabilities22,500     
Total noncurrent liabilities:22,500     
Total liabilities:2,197,1352,504,1703,254,2082,810,2871,585,295450,724
Equity
Equity, attributable to parent7,961,8761,620,1557,416,38422,274,74041,276,99130,916,490
Common stock3,29110,8611,48648,10647,87443,118
Additional paid in capital178,986,981156,408,737141,103,178125,054,453119,246,97089,295,601
Accumulated deficit(171,028,396)(154,799,443)(133,688,280)(102,827,819)(78,017,853)(58,422,229)
Total equity:7,961,8761,620,1557,416,38422,274,74041,276,99130,916,490
TOTAL LIABILITIES AND EQUITY:10,159,0114,124,32510,670,59225,085,02742,862,28631,367,214

Income Statement (P&L) (USD)

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues      
Realized investment gains (losses)(299)(570)    
Cost of revenue  (6,693)(15,004)(25,575)(22,534)(22,777)
Gross profit: (6,693)(15,004)(25,575)(22,534)(22,777)
Operating expenses(15,515,619)(21,167,474)(31,060,566)(23,805,144)(19,578,223)(17,938,804)
Other undisclosed operating income (loss)299     
Operating loss:(15,515,619)(21,174,167)(31,075,570)(23,830,719)(19,600,757)(17,961,581)
Nonoperating income (expense)(713,035)63,574215,10990,0985,13318,811
Investment income, nonoperating 63,574215,10990,0985,13318,811
Other nonoperating expense(713,035)     
Loss from continuing operations:(16,228,654)(21,110,593)(30,860,461)(23,740,621)(19,595,624)(17,942,770)
Loss before gain (loss) on sale of properties:✕✕✕✕✕(19,595,624)(17,942,770)
Net loss:(16,228,654)(21,110,593)(30,860,461)(23,740,621)(19,595,624)(17,942,770)
Other undisclosed net income (loss) attributable to parent(299)(570)    
Net loss attributable to parent:(16,228,953)(21,111,163)(30,860,461)(23,740,621)(19,595,624)(17,942,770)
Other undisclosed net loss available to common stockholders, basic  (277,119)    
Net loss available to common stockholders, diluted:(16,228,953)(21,388,282)(30,860,461)(23,740,621)(19,595,624)(17,942,770)

Comprehensive Income (USD)

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net loss:(16,228,654)(21,110,593)(30,860,461)(23,740,621)(19,595,624)(17,942,770)
Comprehensive loss, net of tax, attributable to parent:(16,228,654)(21,110,593)(30,860,461)(23,740,621)(19,595,624)(17,942,770)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: